Saudi Central Bank’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Saudi Central Bank's RPRX Position: Q3 2026 in Review
Saudi Central Bank increased its Royalty Pharma (RPRX) stake by 46% in Q3 2026, buying an estimated $780K and bringing the position to 41,989 shares worth $2.45M. The position accounts for 0.02% of the portfolio, ranked #365.
Saudi Central Bank first reported a position in RPRX in Q1 2025 and has held it in 4 quarters since. 707 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Saudi Central Bank held 41,989 shares of Royalty Pharma worth $2.45M as of Q3 2026.
- Saudi Central Bank bought 13,216 Royalty Pharma shares in Q3 2026, an estimated $780K.
- Royalty Pharma made up 0.02% of Saudi Central Bank's portfolio in Q3 2026, its #365 holding.
- Saudi Central Bank first reported a position in Royalty Pharma in Q1 2025 and has held it in 4 quarters since.
- 707 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Saudi Central Bank's 13F filing for Q3 2026, filed 13 Nov 2026.